BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 30417576)

  • 1. Zbed3 promotes proliferation and invasion of lung cancer partly through regulating the function of Axin-Gsk3β complex.
    Shi X; Zhao Y; Fan C
    J Cell Mol Med; 2019 Feb; 23(2):1014-1021. PubMed ID: 30417576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The function of BED finger domain of Zbed3 in regulating lung cancer cell proliferation.
    Liu H; Shi X; Fan X; Zhang D; Jiang B; Zhao Y; Fan C
    J Cell Biochem; 2019 Aug; 120(8):12340-12347. PubMed ID: 30805970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of zinc-finger BED domain-containing 3 (Zbed3) as a novel Axin-interacting protein that activates Wnt/beta-catenin signaling.
    Chen T; Li M; Ding Y; Zhang LS; Xi Y; Pan WJ; Tao DL; Wang JY; Li L
    J Biol Chem; 2009 Mar; 284(11):6683-9. PubMed ID: 19141611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zbed3 contributes to malignant phenotype of lung cancer via regulating β-catenin and P120-catenin 1.
    Fan C; Jiang G; Zhang X; Miao Y; Lin X; Luan L; Xu Z; Zhang Y; Zhao H; Liu D; Wang E
    Mol Carcinog; 2015 Jun; 54 Suppl 1():E138-47. PubMed ID: 25263389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Axin downregulates TCF-4 transcription via beta-catenin, but not p53, and inhibits the proliferation and invasion of lung cancer cells.
    Yang LH; Xu HT; Han Y; Li QC; Liu Y; Zhao Y; Yang ZQ; Dong QZ; Miao Y; Dai SD; Wang EH
    Mol Cancer; 2010 Feb; 9():25. PubMed ID: 20122174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mdig suppresses epithelial-mesenchymal transition and inhibits the invasion and metastasis of non‑small cell lung cancer via regulating GSK-3β/β-catenin signaling.
    Geng F; Jiang Z; Song X; Zhou H; Zhao H
    Int J Oncol; 2017 Dec; 51(6):1898-1908. PubMed ID: 29039479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CDX2 inhibits the proliferation and tumor formation of colon cancer cells by suppressing Wnt/β-catenin signaling via transactivation of GSK-3β and Axin2 expression.
    Yu J; Liu D; Sun X; Yang K; Yao J; Cheng C; Wang C; Zheng J
    Cell Death Dis; 2019 Jan; 10(1):26. PubMed ID: 30631044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-552-3p facilitated cell proliferation, migration and invasion by sponging Fibulin 5 in non-small cell lung cancer via activation of ERK/GSK3β/β-catenin signaling pathway.
    Huang M; Liao X; Li L; Li G; Chen M
    Tissue Cell; 2021 Dec; 73():101672. PubMed ID: 34736163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Axin, an inhibitor of the Wnt signalling pathway, interacts with beta-catenin, GSK-3beta and APC and reduces the beta-catenin level.
    Nakamura T; Hamada F; Ishidate T; Anai K; Kawahara K; Toyoshima K; Akiyama T
    Genes Cells; 1998 Jun; 3(6):395-403. PubMed ID: 9734785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silencing of lemur tyrosine kinase 2 restricts the proliferation and invasion of hepatocellular carcinoma through modulation of GSK-3β/Wnt/β-catenin signaling.
    Zhao G; Song Y; Dong L; Shi H; Li H; Yang L; Wang J
    Biochem Biophys Res Commun; 2019 Oct; 517(4):722-728. PubMed ID: 31395338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curcumin inhibits the growth via Wnt/β-catenin pathway in non-small-cell lung cancer cells.
    Wang JY; Wang X; Wang XJ; Zheng BZ; Wang Y; Wang X; Liang B
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7492-7499. PubMed ID: 30468498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A small molecule compound 759 inhibits the wnt/beta-catenin signaling pathway via increasing the Axin protein stability.
    Sun S; Gong YD; Kang JS; Dong MS; Choi Y
    Med Oncol; 2024 May; 41(6):147. PubMed ID: 38733492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ATF4 promotes lung cancer cell proliferation and invasion partially through regulating Wnt/β-catenin signaling.
    Du J; Liu H; Mao X; Qin Y; Fan C
    Int J Med Sci; 2021; 18(6):1442-1448. PubMed ID: 33628101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-1246 Promotes Metastasis and Invasion of A549 cells by Targeting GSK-3β‒Mediated Wnt/β-Catenin Pathway.
    Yang F; Xiong H; Duan L; Li Q; Li X; Zhou Y
    Cancer Res Treat; 2019 Oct; 51(4):1420-1429. PubMed ID: 30913872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galangin suppresses the proliferation of β-catenin response transcription-positive cancer cells by promoting adenomatous polyposis coli/Axin/glycogen synthase kinase-3β-independent β-catenin degradation.
    Gwak J; Oh J; Cho M; Bae SK; Song IS; Liu KH; Jeong Y; Kim DE; Chung YH; Oh S
    Mol Pharmacol; 2011 Jun; 79(6):1014-22. PubMed ID: 21406604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNF6 promotes colorectal cancer invasion and migration via the Wnt/β-catenin pathway by inhibiting GSK3β activity.
    Li Q; Wang G; Tao J; Chen W
    Pathol Res Pract; 2021 Sep; 225():153545. PubMed ID: 34352441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bridging of beta-catenin and glycogen synthase kinase-3beta by axin and inhibition of beta-catenin-mediated transcription.
    Sakanaka C; Weiss JB; Williams LT
    Proc Natl Acad Sci U S A; 1998 Mar; 95(6):3020-3. PubMed ID: 9501208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ATDC promotes the growth and invasion of hepatocellular carcinoma cells by modulating GSK-3β/Wnt/β-catenin signalling.
    Li W; Xue H; Li Y; Li P; Ma F; Liu M; Kong S
    Clin Exp Pharmacol Physiol; 2019 Sep; 46(9):845-853. PubMed ID: 31168819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the NAD
    Ye C; Qi L; Li X; Wang J; Yu J; Zhou B; Guo C; Chen J; Zheng S
    Cell Commun Signal; 2020 Jan; 18(1):16. PubMed ID: 32005247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stabilizing and upregulating Axin with tankyrase inhibitor reverses 5-fluorouracil chemoresistance and proliferation by targeting the WNT/caveolin-1 axis in colorectal cancer cells.
    Luo F; Li J; Liu J; Liu K
    Cancer Gene Ther; 2022 Nov; 29(11):1707-1719. PubMed ID: 35750753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.